Dr. Rachel V. Gow

I’ve gained a great deal of experience and skill in the design, administration, management and life-cycle of clinical trials, from the initial design ideas to the subsequent stages of protocol writing, ethical approval, recruitment, management of trial activity, timelines and expenditure, and through to the final stages of completion, statistical analyses and write up. My first experience in this area was in 2007, when I assisted in a phase III clinical trial testing the safety and efficacy of omega-3 fatty acids in children and adolescents with ADHD. The principle investigator of this trial was Professor Eric Taylor (Emeritus), who at the time was head of the Department of Child and Adolescent Psychiatry at the Institute of Psychiatry, Kings College, London. The clinical trial was named the Maudsley Adolescent ADHD Fatty Acid trial (MAAFA). It was the pioneering idea of Professor Taylor and a novel effort to combine the fields of psychiatry and nutrition.